Application no. and date | 18715026.3 (espacenet) (Federated) (European Patent Register), 20180403 | Patent/reg. no. and date | DK/EP 3606954, 20220720 | Publication date | 20200212 | Priority no. and date | EP 17164917, 20170405 | EP pub. no. and date |
EP 3606954 20200212 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | P80683DK01 | Inventor | FISCHER, Jens, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE, SEEBER, Stefan, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE, ZWICK, Adrian, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE, DENGL, Stefan, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE, KLEIN, Christian, c/o Roche Glycart AG Wagistrasse 10
8952 Schlieren, CH, CODARRI DEAK, Laura, c/o Roche Glycart AG Wagistrasse 10
8952 Schlieren, CH, WEBER, Patrick Alexander Aaron, c/o Roche Glycart AG Wagistrasse 10
8952 Schlieren, CH | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | Title | Anti-LAG3-antistoffer | Int. application no. | EP2018058385 | Int. publication no. | WO2018185046 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|